Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Kleemann

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Herz|October 27, 2018
[Which way does modern pacemaker therapy go?]T Kleemann
Herz|October 9, 2015
[Cardiac contractility modulation. A new form of therapy for patients with heart failure and narrow QRS complex?]T Kleemann
Herzschrittmachertherapie & Elektrophysiologie|May 28, 2010
[ICD therapy as secondary prevention]K Seidl, M Strauss, T Kleemann
Herz|October 4, 2018
[Pacemaker and MRI in clinical practice]A Fendt, M Strauß, K Kouraki, et al.
Herzschrittmachertherapie & Elektrophysiologie|April 12, 2011
Additional coronary sinus defibrillation lead with a right pectoral ICD and high DFT : a case reportM Strauss, T Kleemann, U Weisse, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|November 23, 2006
The prognostic impact of successful cardioversion of atrial fibrillation in patients with organic heart diseaseT Kleemann, T Becker, K Dönges, et al.
Zeitschrift Fur Kardiologie|October 6, 2000
[1998 prognosis of left ventricular dysfunction in a maximum care non-university hospital. Analysis of the Ludwigshafen LVD Registry]G Taubert, T Kottmann, A K Gitt, et al.
European Journal of Neurology|July 14, 2012
Stroke due to atrial fibrillation in a population-based stroke registry (Ludwigshafen Stroke Study) CHADS(2) , CHA(2) DS(2) -VASc score, underuse of oral anticoagulation, and implications for preventive measuresF Palm, T Kleemann, M Dos Santos, et al.
Cerebrovascular Diseases (Basel, Switzerland)|December 3, 2011
Etiology, risk factors and sex differences in ischemic stroke in the Ludwigshafen Stroke Study, a population-based stroke registryF Palm, C Urbanek, J Wolf, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Herz|October 27, 2018
[Which way does modern pacemaker therapy go?]T Kleemann
Herz|October 9, 2015
[Cardiac contractility modulation. A new form of therapy for patients with heart failure and narrow QRS complex?]T Kleemann
Herzschrittmachertherapie & Elektrophysiologie|May 28, 2010
[ICD therapy as secondary prevention]K Seidl, M Strauss, T Kleemann
Herz|October 4, 2018
[Pacemaker and MRI in clinical practice]A Fendt, M Strauß, K Kouraki, et al.
Herzschrittmachertherapie & Elektrophysiologie|April 12, 2011
Additional coronary sinus defibrillation lead with a right pectoral ICD and high DFT : a case reportM Strauss, T Kleemann, U Weisse, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|November 23, 2006
The prognostic impact of successful cardioversion of atrial fibrillation in patients with organic heart diseaseT Kleemann, T Becker, K Dönges, et al.
Zeitschrift Fur Kardiologie|October 6, 2000
[1998 prognosis of left ventricular dysfunction in a maximum care non-university hospital. Analysis of the Ludwigshafen LVD Registry]G Taubert, T Kottmann, A K Gitt, et al.
European Journal of Neurology|July 14, 2012
Stroke due to atrial fibrillation in a population-based stroke registry (Ludwigshafen Stroke Study) CHADS(2) , CHA(2) DS(2) -VASc score, underuse of oral anticoagulation, and implications for preventive measuresF Palm, T Kleemann, M Dos Santos, et al.
Cerebrovascular Diseases (Basel, Switzerland)|December 3, 2011
Etiology, risk factors and sex differences in ischemic stroke in the Ludwigshafen Stroke Study, a population-based stroke registryF Palm, C Urbanek, J Wolf, et al.
Pageof 1